Event Details

Approximately 2007-2008

Description

General Nadeem Taj was removed from DG/ISI under intense pressure from Washington.

Participants (2)

Name Type Mentions
General Nadeem Taj person 2 View Entity
Administration organization 376 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_029647.tif

Report/Analysis • 66.8 KB
View

This document details the career and alleged complicity of General Nadeem Taj, a former DG/ISI, in various militant activities. It describes his role in orchestrating a coup for Pervez Musharraf, his command of the Kakul Military Academy near bin Laden's hideout, and accusations of ISI involvement in the 2008 Indian embassy bombing in Kabul, undermining drone programs, and planning the Mumbai attack.

Related Events

Events with shared participants

The Administration's proposal in the 2008 Budget to consolidate DOJ's grant programs.

2008-01-01

View

Planned construction of a 12,770 SF facility for U.S. Citizenship and Immigration Services, intended as a mission-critical consolidation of CIS offices.

2015-01-01 • St. Thomas, U.S. Virgin Islands

View

A 'GSA Investment & Acquisition Opportunity' presented by Stan Johnson Company for a property in St. Thomas, USVI, apparently for lease to the Department of Homeland Security.

Date unknown • St. Thomas, USVI

View

The highlighted property, 'MGM GRAND THE LOT', received a '505' FAA Approval', permitting construction up to a height of 505 feet.

Date unknown • MGM GRAND THE LOT, Las Vegas, NV

View

Issuance of FAA Height Determination Letters.

2011-01-01 • Undisclosed property, likely in Clark County, NV

View

Height Determination Letter issued by the FAA.

2011-05-01 • Clark County (inferred)

View

Article about 'The Trump administration's attack on the Chesapeake Bay'.

Date unknown • Chesapeake Bay

View

The US Congress unanimously passed the Taiwan Travel Act, which encourages the Trump administration to host more high-ranking officials from Taiwan.

2018-01-01 • United States

View

The U.S. Food and Drug Administration (FDA) approved Praluent, a new cholesterol-lowering injectable drug.

2015-07-24

View

Release of the administration's College Scorecard.

Date unknown • N/A

View

Event Metadata

Type
Unknown
Location
Washington
Significance Score
5/10
Participants
2
Source Documents
1
Extracted
2025-12-26 15:26

Additional Data

Source
HOUSE_OVERSIGHT_029647.tif
Date String
Approximately 2007-2008

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event